MedPath

The Effect of Aroma on Anxiety Among Children With Autism.

Not Applicable
Withdrawn
Conditions
Anxiety
Autism Spectrum Disorder
Interventions
Other: Control Blend
Other: Test Essential Oil Blend
Other: Active Essential Oil Blend
Registration Number
NCT03489811
Lead Sponsor
Franklin Health Research
Brief Summary

This study evaluates the effects of essential oils on anxiety scores among children who have an autism spectrum disorder. One third of the children will receive a control blend of oils, one third of the children will receive a test blend of oils, and the other third will receive a second test blend of oils.

Detailed Description

Essential oils have been found in studies to reduce both stress and anxiety as measured by an anxiety inventory, but studies have not tested these effects among children who have an autism spectrum disorder.

The essential oils used in this study are administered each morning for a total period of four weeks, with an optional second exposure on an as-needed basis during the final two of the four weeks of the study. The oils are administered during this time to evaluate both the preventive effects and the treatment effects of the essential oils.

Anxiety is measured on an anxiety inventory, which is completed by the parent of the participant at the end of each week during the study. Parents complete this data online, allowing them to participate from anywhere in the U.S.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • age: 6-11 years old at enrollment
  • diagnosed with an autism spectrum disorder
Exclusion Criteria
  • mast cell activation syndrome
  • history of adverse response to essential oil inhalation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlControl BlendParticipants in this arm receive a control inhaler to administer during the 4-week intervention.
Test Essential Oil BlendTest Essential Oil BlendParticipants in this arm receive the test essential oil inhaler to administer during the 4-week intervention.
Active Essential Oil BlendActive Essential Oil BlendParticipants in this arm receive an active essential oil inhaler to administer during the 4-week intervention.
Primary Outcome Measures
NameTimeMethod
39-Question Spence Children's Anxiety Scale (SCAS)baseline and day 35

The Spence Children's Anxiety Scale collects parent-reported signs and symptoms of anxiety at baseline and again at the end of each week of the intervention. Each item is scored as (0) never, (1) sometimes (2) often, or (3)always. The total score ranges from 0-114, with higher scores indicating higher levels of anxiety.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Franklin Institute of Wellness

🇺🇸

Franklin, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath